2017
DOI: 10.1371/journal.pone.0182929
|View full text |Cite
|
Sign up to set email alerts
|

Medication eluting devices for the field of OBGYN (MEDOBGYN): 3D printed biodegradable hormone eluting constructs, a proof of concept study

Abstract: 3D printing has the potential to deliver personalized implants and devices for obstetric and gynecologic applications. The aim of this study is to engineer customizable and biodegradable 3D printed implant materials that can elute estrogen and/or progesterone. All 3D constructs were printed using polycaprolactone (PCL) biodegradable polymer laden with estrogen or progesterone and were subjected to hormone-release profile studies using ELISA kits. Material thermal properties were tested using thermogravimetric … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
51
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1
1

Relationship

2
5

Authors

Journals

citations
Cited by 90 publications
(56 citation statements)
references
References 19 publications
(17 reference statements)
0
51
0
2
Order By: Relevance
“…Previously (9) reported in vitro studies show that 3D printed vascular stent constructs could be iodized, which made these constructs highly resistant to supporting bacterial growth in culture assays. Tappa et al (10) incorporated estrogen and progesterone into 3D printed intrauterine devices which demonstrated the utility of such devices as contraceptives and drug-delivery devices. Such incorporation of drugs and hormones into 3D printed insert spacers represents a novel approach to further ‘customize’ migration/invasion assays using the advantage of 3D printing technologies to study migration and repulsion effects of materials introduced into the inserts used in such assays.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previously (9) reported in vitro studies show that 3D printed vascular stent constructs could be iodized, which made these constructs highly resistant to supporting bacterial growth in culture assays. Tappa et al (10) incorporated estrogen and progesterone into 3D printed intrauterine devices which demonstrated the utility of such devices as contraceptives and drug-delivery devices. Such incorporation of drugs and hormones into 3D printed insert spacers represents a novel approach to further ‘customize’ migration/invasion assays using the advantage of 3D printing technologies to study migration and repulsion effects of materials introduced into the inserts used in such assays.…”
Section: Discussionmentioning
confidence: 99%
“…3D printing is projected to be a disruptive manufacturing technology, which may enable labs around the world to fabricate custom assays in house and on-demand. 3D printing technologies also have ability to easily incorporate many bioactive test substances including antibiotics, chemotherapeutics, and hormones either as a pre-print additive or a post-print binder (410). These compositional and surface modifications allow highly complex models to be created which can even incorporate bioprinting (11,12).…”
Section: Introductionmentioning
confidence: 99%
“…Implants and procedural devices, take advantage of the customizability, manufacturing capabilities, and potential low cost of additive manufacturing techniques. 3D printing not only allows implants and procedural tools to be tailored to patient-specific anatomy, it allows products to be manufactured with bland or drug-impregnated materials (56-59). 3D printed biologically active implants are discussed in the Bioprinting Revolution section.…”
Section: Introductionmentioning
confidence: 99%
“…Bioprinting involves the use of various techniques, such as fused deposition modeling, to print bioactive scaffolds impregnated with growth factors designed to stimulate regeneration or drugs that concentrate their activity in the microenvironment, print customized bioactive implants and devices on demand, even generate customized living tissues (56-59, 101, 102). …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation